Bridge Medicines
Sioux Falls
About Bridge Medicines
Bridge Medicines is a drug discovery company launched in partnership with Memorial Sloan Kettering Cancer Center, The Rockefeller University, Weill Cornell Medicine, Takeda Pharmaceutical Company Ltd. and healthcare investment firms Bay City Capital and Deerfield Management. Bridge Medicines is a groundbreaking initiative that completes an unbroken, fully funded and professionally staffed path from concept to drug candidate, to develop efficiently and quickly innovative therapeutics for the treatment of human diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.0M
- Last round: Series Unknown (Nov 2020)
- Website: bridgemedicines.com
Industries & Categories
Pharmaceutical
Canonical: https://fsome.com/organization/bridge-medicines-139860 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.